China Pharma Holdings (CPHI) Retained Earnings (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Retained Earnings came in at $12.0 million in Q1 2026, up 6.08% YoY from $11.3 million in Q1 2025, and down 79.47% on a QoQ basis from $58.5 million in Q4 2025.
China Pharma Holdings (CPHI) Retained Earnings (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Retained Earnings data on file, last reported at $12.0 million in Q1 2026.
- Quarterly Retained Earnings rose 6.08% year-over-year to $12.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (up 6.08% YoY) and the FY2025 annual result came in at $58.5 million, up 417.12% from the prior year.
- Retained Earnings fell to $12.0 million in Q1 2026, from $58.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $58.5 million in Q4 2025 to a low of -$46.0 million in Q3 2025.
- A 5-year average of $2.0 million and a median of $11.4 million in 2024 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 417.12% in 2025, down 499.21% in 2025.
- Tracing CPHI's Retained Earnings over 5 years: stood at -$36.2 million in 2022, then soared by 197.43% to $35.3 million in 2023, then slumped by 67.92% to $11.3 million in 2024, then jumped by 417.12% to $58.5 million in 2025, then plunged by 79.47% to $12.0 million in 2026.
- The last three Retained Earnings figures came in at $12.0 million (Q1 2026), $58.5 million (Q4 2025), and -$46.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.75 Bn |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | 73.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.02 Mn |
| Dec 31, 2025 | 58.54 Mn |
| Sep 30, 2025 | -46.00 Mn |
| Jun 30, 2025 | -45.34 Mn |
| Mar 31, 2025 | 11.33 Mn |
| Dec 31, 2024 | 11.32 Mn |
| Sep 30, 2024 | 11.52 Mn |
| Jun 30, 2024 | 37.69 Mn |
| Mar 31, 2024 | 11.43 Mn |
| Dec 31, 2023 | 35.28 Mn |
| Sep 30, 2023 | -38.06 Mn |
| Jun 30, 2023 | -37.28 Mn |
| Mar 31, 2023 | 29.49 Mn |
| Dec 31, 2022 | -36.21 Mn |
| Sep 30, 2022 | 26.34 Mn |
| Jun 30, 2022 | -34.16 Mn |
| Mar 31, 2022 | 25.94 Mn |
| Dec 31, 2021 | 25.65 Mn |
| Sep 30, 2021 | 25.65 Mn |
| Jun 30, 2021 | -30.43 Mn |